QINGSONG HEALTH(02661)pricing IPO at HK$22.68 X

15/12/2025 11:34

(Infocast News) QINGSONG HEALTH(02661) is expected to start its initial public offering on 15 October 2025. Details of the IPO are as follows:

Shares for offer: 26.54M shares, of which 90% are for international placing and 10% are for Hong Kong public offering, with an option to offer an additional 15% shares

Offer price: HK$22.68 per share

Gross proceeds: HK$601.9 million

Net proceeds: HK$513.4 million

- Approximately 40% will be used to enhance the Group's brand awareness, increase user engagement, and strengthen cooperation with business partners;

- Approximately 20% will be used for medical research and real-world research;

- Approximately 20% will be used to enhance the Group's technological capabilities in AI and big data, so as to apply them more broadly to our products and services;

- Approximately 10% will be used to expand into more regions and overseas markets; and

- Approximately 10% will be used for working capital and other general corporate purposes.

Board lot size: 200 shares

IPO entry fee: HK$4581.75

Offer period: December 15 to noon on December 18

Listing date: December 23

Sponsors: China International Capital Corporation (CICC) and China Merchants Securities International; other arrangers include Futu Securities and SPDB International.

EIPO: www.eipo.com.hk、FINI (lunatemp)

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.